Company intelligence / Profile preview

ZüriPharm

Schlieren, Zürich, Switzerlandusz.ch ↗

Ownership: Private
Employees: ~125
Development stage: Commercial

Overview

ZüriPharm AG is one of Switzerland’s leading hospital pharmacy competence centers. It provides individualized pharmaceuticals, galenic development, industrial-scale GMP production, and technology transfer services. The company collaborates with academic institutions to accelerate the translation of innovative therapies from research to clinical application.

Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Wyss Zurich Regenerative Medicine Technologies Platform / University of Zurich – strategic partnership for translational medicine and innovative therapies

Beyond the preview

Go deeper on ZüriPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZüriPharm.

Explore the full profile